CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

Eva Marie Uzcategui / Bloomberg / Getty Images CVS Health reported better-than-expected quarterly results, and the new CEO ...

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, Steve Nelson, a former UnitedHealthcare CEO.

In 2024, retail health care faced significant disruption as industry giants like Walgreens, CVS and Walmart reevaluated their ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

Leverage Ratio: Approximately 4.6 times. CVS Health Corp (NYSE:CVS) achieved a record high retail pharmacy script share of 27.3%, indicating strong market presence. The company introduced Simple ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

CVS Health (NYSE:CVS) just rocked the market with a nearly 11% surge in pre-market trading after its Q3 revenue topped expectations, hitting a staggering $95.4 billion. This beat, the first of ...

We recently compiled a list of the Jim Cramer’s Latest Game Plan: 15 Stocks to Watch. In this article, we are going to take a ...